iMD Companies and Its Subsidiary Riize, Open and Launch Telemedicine Platform in Canada
iMD Companies, Inc. (OTC: ICBU) and its subsidiary Riize Health have launched their telemedicine platform in Canada, meeting their projected start date of late September to early October 2024. The platform offers the same pharmaceutical and medical practitioner solutions for sexual wellness products that have driven growth in the U.S. market.
Riize Health's 100% online system provides discreet access to licensed medical professionals for personal health product assessments and prescriptions. The company plans to expand its product line to include Hair Growth in Q4, followed by Testosterone Replacement Therapy (TRT) and Hormone Replacement Therapy (HRT) products.
This international expansion is seen as a key step for iMD Companies' revenue projections and future growth opportunities. The company is positioning itself as an innovative provider in the men's and women's personal health care market.
iMD Companies, Inc. (OTC: ICBU) e la sua sussidiaria Riize Health hanno lanciato la loro piattaforma di telemedicina in Canada, rispettando la data di inizio prevista per la fine di settembre all'inizio di ottobre 2024. La piattaforma offre le stesse soluzioni farmaceutiche e per medici specializzati per i prodotti di benessere sessuale che hanno guidato la crescita nel mercato statunitense.
Il sistema completamente online di Riize Health fornisce accesso riservato a professionisti medici autorizzati per valutazioni sui prodotti per la salute personale e prescrizioni. L'azienda prevede di espandere la propria linea di prodotti per includere la crescita dei capelli nel quarto trimestre, seguita da prodotti per la terapia sostitutiva del testosterone (TRT) e la terapia ormonale sostitutiva (HRT).
Questa espansione internazionale è vista come un passo fondamentale per le proiezioni di entrate di iMD Companies e per le future opportunità di crescita. L'azienda si sta posizionando come fornitore innovativo nel mercato della salute personale per uomini e donne.
iMD Companies, Inc. (OTC: ICBU) y su subsidiaria Riize Health han lanzado su plataforma de telemedicina en Canadá, cumpliendo con la fecha de inicio proyectada para finales de septiembre a principios de octubre de 2024. La plataforma ofrece las mismas soluciones farmacéuticas y para profesionales médicos para productos de bienestar sexual que han impulsado el crecimiento en el mercado estadounidense.
El sistema 100% en línea de Riize Health proporciona acceso discreto a profesionales médicos licenciados para evaluaciones de productos de salud personal y recetas. La compañía planea ampliar su línea de productos para incluir el crecimiento del cabello en el cuarto trimestre, seguido de productos para terapia de reemplazo de testosterona (TRT) y terapia de reemplazo hormonal (HRT).
Esta expansión internacional se considera un paso clave para las proyecciones de ingresos de iMD Companies y oportunidades de crecimiento futuro. La compañía se está posicionando como un proveedor innovador en el mercado de atención médica personal para hombres y mujeres.
iMD Companies, Inc. (OTC: ICBU)와 그 자회사인 Riize Health가 캐나다에 원격 의료 플랫폼을 출시했습니다, 2024년 9월 말에서 10월 초의 예상 시작일에 맞췄습니다. 이 플랫폼은 미국 시장에서의 성 건강 제품에 대한 성장을 이끌어 온 동일한 제약 및 의료 전문가 솔루션을 제공합니다.
Riize Health의 100% 온라인 시스템은 면허가 있는 의료 전문가에 대한 비밀스러운 접근을 제공하여 개인 건강 제품 평가 및 처방을 수행합니다. 이 회사는 4분기에 모발 성장 제품을 포함하도록 제품 라인을 확장할 계획이며, 이어서 테스토스테론 대체 요법 (TRT) 및 호르몬 대체 요법 (HRT) 제품을 추가할 예정입니다.
이번 국제적 확장은 iMD Companies의 수익 예측과 향후 성장 기회의 중요한 단계로 평가되고 있습니다. 이 회사는 남성과 여성 개인 건강 관리 시장에서 혁신적인 공급자로 자리매김하고 있습니다.
iMD Companies, Inc. (OTC: ICBU) et sa filiale Riize Health ont lancé leur plateforme de télémédecine au Canada, respectant la date de début prévue à la fin septembre ou début octobre 2024. La plateforme propose les mêmes solutions pharmaceutiques et médicales pour les produits de bien-être sexuel qui ont stimulé la croissance sur le marché américain.
Le système entièrement en ligne de Riize Health offre un accès discret à des professionnels de santé agréés pour des évaluations de produits de santé personnels et des prescriptions. L'entreprise prévoit d'élargir sa gamme de produits pour inclure la croissance des cheveux au quatrième trimestre, suivie de produits de thérapie de remplacement de testostérone (TRT) et de thérapie de remplacement hormonal (HRT).
Cette expansion internationale est considérée comme une étape clé pour les prévisions de revenus d'iMD Companies et les opportunités de croissance futures. L'entreprise se positionne comme un fournisseur innovant sur le marché des soins de santé personnels pour hommes et femmes.
iMD Companies, Inc. (OTC: ICBU) und ihre Tochtergesellschaft Riize Health haben ihre Telemedizin-Plattform in Kanada gestartet und die geplante Startzeit von Ende September bis Anfang Oktober 2024 eingehalten. Die Plattform bietet dieselben pharmazeutischen und medizinischen Lösungen für Produkte zur sexuellen Gesundheit, die das Wachstum im US-Markt vorangetrieben haben.
Das 100% online-basierte System von Riize Health bietet diskreten Zugang zu lizenzierten medizinischen Fachkräften für persönliche Gesundheitsprodukteinschätzungen und Rezepte. Das Unternehmen plant, die Produktlinie zu erweitern, um im vierten Quartal Produkte für Haarwachstum hinzuzufügen, gefolgt von Testosteron-Ersatztherapie (TRT) und Hormon-Ersatztherapie (HRT) Produkten.
Diese internationale Expansion wird als wichtiger Schritt für die Umsatzprognosen von iMD Companies und zukünftige Wachstumschancen angesehen. Das Unternehmen positioniert sich als innovativer Anbieter im Markt für persönliche Gesundheitsversorgung für Männer und Frauen.
- Successful expansion into the Canadian market, meeting projected launch date
- Plans to introduce new product lines: Hair Growth, TRT, and HRT
- Potential for increased revenue through international expansion
- None.
RANCHO CORDOVA, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) and its subsidiary Riize, LLC (Riize Health) has completed the target expansion into the Canadian marketplace.
The Riize Health telemedicine platform has officially been approved and we’re now taking orders in Canada. The platform incorporates the same pharmaceutical and medical practitioner solutions that continue to produce dynamic growth in the U.S. for its sexual wellness product lines.
We’re proud to have met the original projected Canadian start date of end of September to early October 2024. Reilly Schueler, CEO of Riize Health, states, "We are very excited about the potential for new and continued growth with the addition of our international operations in Canada. As part of IMD Companies, we look forward to this additional new market opportunity as well as growth into other areas. We couldn’t be happier."
Riize Health's
In addition to the success of its core sexual wellness products, Riize Health anticipates adding a product line for Hair Growth in Q4, followed by products for TRT (Testosterone Replacement Therapy) and HRT (Hormone Replacement Therapy) in the coming weeks, further establishing itself as an innovative provider to the men's and women's personal health care market.
Rick Wilson, President and CEO of iMD Companies, Inc., states, “Having the ability to be an International Company and finalize the strategic launch in Canada with our amazing subsidiary Riize, enables iMD Companies to look at other International opportunities in the near future as well. Our product line expansion and entry into new markets is key to our revenue projections.”
Follow Riize Social Media
Website @ https://www.riizehealth.com
Canada @ ca.riizehealth.com
Facebook @ https://www.facebook.com/riizehealth
Instagram @ https://www.instagram.com/riizehealth/
Tiktok @ https://www.tiktok.com/@riize_up_llc
Blogs @ https://riizehealth.com/pages/recent-blog-post
About Riize, LLC
Riize is revolutionizing the healthcare industry as a leading telemedicine/pharmacy services provider. Our specialized focus on men’s and women’s sexual health and weight loss sets us apart from the competition due to our revolutionary delivery system. We are proud to offer a convenient and innovative online healthcare service that connects individuals with licensed healthcare providers. At Riize, we understand the importance of personalized care. That’s why we provide a platform where patients can easily consult with healthcare professionals remotely. Through video or phone calls, individuals can discuss their symptoms, receive accurate diagnoses, and obtain personalized treatment plans that address their specific needs. We believe in breaking down barriers to healthcare access. With Riize, patients no longer have to endure long wait times or travel to a physical clinic. Our user-friendly platform ensures that quality healthcare is just a few clicks away. Join us in shaping the future of healthcare. Experience the convenience and expertise that Riize offers. Your health and well-being are our priorities.
Follow iMD Companies, Inc. Social Media
Twitter @ https://twitter.com/imd_inc
Instagram @ https://www.instagram.com/imdcompaniesinc/
About iMD Companies, Inc.
iMD Companies. Inc. (OTC: ICBU) is a Florida Corporation. The company has been re-positioned to be a holding company for acquisitions and technology development in the health care markets. iMD's goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace.
Safe Harbor Statement
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Contact:
iMD Companies, Inc.
info@imdcompaniesinc.com
FAQ
When did iMD Companies (ICBU) launch its telemedicine platform in Canada?
What new product lines is Riize Health planning to introduce?
How does the Riize Health telemedicine platform operate?
What is the significance of iMD Companies' (ICBU) expansion into Canada?
